Sullivan Patrick M, Harrison David, Badran Sarah, Takao Cheryl M, Ing Frank F
Division of Pediatric Cardiology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Children's Hospital Los Angeles Heart Center, 4650 Sunset Blvd., #34, Los Angeles, CA, USA.
Pediatr Cardiol. 2017 Dec;38(8):1583-1591. doi: 10.1007/s00246-017-1700-z. Epub 2017 Aug 2.
The objective of this study was to compare radiation doses and imaging quality using Philips AlluraClarity (Philips Healthcare, Best, The Netherlands) X-ray system and an older generation reference system. AlluraClarity is a new generation fluoroscopy system designed to reduce radiation without compromising image quality, but reports of its use in pediatric patients are limited. Dose area products (DAP, mGy cm) and DAP/kg were compared in patients catheterized using Allura Xper and AlluraClarity systems over a year of use for each. Randomly selected studies from each system were assessed for image quality. The 430 patients imaged with Clarity were larger than the 332 imaged with Xper (median BSA: 0.74 vs. 0.64 m, p = 0.06), and median total fluoroscopic times (TFT) were similar (15.8 vs. 16.1 min, p = 0.37). Median DAPs were 8661 mGy cm (IQR: 18,300 mGy cm) and 4523 mGy cm (IQR: 11,596 mGy cm) with Xper and Clarity, respectively (p < 0.001). There was a reduction in median DAP in all procedure categories. After adjustment for BSA, TFT, and procedure type, using Clarity was associated with a 57.5% (95% CI 51.5-62.8%, p < 0.001) reduction in DAP for all procedures. Reductions did not significantly differ by weight (<10 kg, 10-40 kg, ≥ 40 kg). There was an adjusted percent reduction in DAP for each procedure category ranging from 39.0% (95% CI 25.6-50.1%, p < 0.001) for cardiac biopsies with or without coronary angiography to 67.6% (95% CI 61.2-72.8%, p < 0.001) for device occlusions. Mean overall imaging quality scores (4.3 ± 0.8 with Clarity vs. 4.4 ± 0.6 with Xper, p = 0.62) and scores based on specific quality parameters were similar in the two groups. Use of AlluraClarity substantially reduced radiation doses compared to the older generation reference system without compromising imaging quality in a pediatric cardiac catheterization lab.
本研究的目的是比较使用飞利浦AlluraClarity(飞利浦医疗保健公司,荷兰贝斯特)X射线系统和一代较旧的参考系统时的辐射剂量和成像质量。AlluraClarity是新一代荧光透视系统,旨在减少辐射且不影响图像质量,但关于其在儿科患者中使用的报告有限。在使用Allura Xper系统和AlluraClarity系统进行导管插入术的患者中,对每个系统使用一年期间的剂量面积乘积(DAP,mGy·cm)和DAP/kg进行了比较。从每个系统中随机选择的研究进行了图像质量评估。使用Clarity成像的430例患者比使用Xper成像的332例患者年龄更大(中位体表面积:0.74 vs. 0.64 m²,p = 0.06),中位总透视时间(TFT)相似(15.8 vs. 16.1分钟,p = 0.37)。使用Xper和Clarity时的中位DAP分别为8661 mGy·cm(IQR:18300 mGy·cm)和4523 mGy·cm(IQR:11596 mGy·cm)(p < .001)。所有程序类别的中位DAP均有所降低。在对体表面积、TFT和程序类型进行调整后,使用Clarity与所有程序的DAP降低57.5%(95%CI 51.5 - 62.8%,p < .001)相关。不同体重组(<10 kg、10 - 40 kg、≥40 kg)的降低幅度无显著差异。每个程序类别的DAP调整后降低百分比范围从有或无冠状动脉造影的心脏活检的39.0%(95%CI 25.6 - 50.1%,p < .001)到装置封堵的67.6%(95%CI 61.2 - 72.8%,p < .001)。两组的平均总体成像质量评分(Clarity为4.3±0.8,Xper为4.4±0.6,p = 0.62)以及基于特定质量参数的评分相似。与一代较旧的参考系统相比,在儿科心脏导管插入实验室中使用AlluraClarity可大幅降低辐射剂量且不影响成像质量。